Acne remains one of the most common dermatologic conditions encountered in pharmacy practice, making pharmacy teams an important resource for helping patients navigate treatment options and safe use. This course reviews recent updates in acne management, including new over-the-counter and prescription treatment options, practical considerations for therapy selection, and upcoming changes to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program. You will be better prepared to support evidence-based acne care, appropriate therapy use, and safe dispensing of isotretinoin.
HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact
GUEST
Jenna Mills, PharmD, BCPS
Associate Professor and Pharmacy Practice Department Vice Chair
University of Findlay
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in over-the-counter and prescription treatment options for acne.
2. Explain key patient-use, safety, and regulatory considerations related to acne therapy, including changes to the iPLEDGE REMS program.
Rachel Maynard and Jenna Mills have no relevant financial relationships to disclose.
0.1 CEU/1.0 Hr
UAN: 0107-0000-26-340-H01-P
Initial release date: 10/12/2026
Expiration date: 10/12/2029
Additional CPE details can be found here.
